within Pharmacolibrary.Drugs.ATC.S;

model S01KX02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 0.05 / 1000000,
    adminCount     = 1,
    Vd             = 0,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Trypan blue is a diazo dye often used as a vital stain to selectively color dead tissues or cells blue. It has been historically used in medicine as a diagnostic agent and is currently approved for use in ophthalmic surgery, particularly in cataract surgery to stain the anterior capsule for enhanced visualization during capsulorhexis.</p><h4>Pharmacokinetics</h4><p>No dedicated pharmacokinetic studies in humans are available for trypan blue. The drug is typically used as a single intraocular dose during cataract surgery, and systemic exposure is considered minimal. Parameters below are estimated/extrapolated as no actual clinical PK model is published.</p><h4>References</h4><ol><li><p>Bergamasco, VD, et al., &amp; Malavazzi, GR (2016). Grooved and nongrooved clear corneal incisions in phacoemulsification: permeability study. <i>European journal of ophthalmology</i> 26(3) 248–251. DOI:<a href=&quot;https://doi.org/10.5301/ejo.5000654&quot;>10.5301/ejo.5000654</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26350992/&quot;>https://pubmed.ncbi.nlm.nih.gov/26350992</a></p></li><li><p>Granholm, AC, et al., &amp; Rose, GM (1996). Development of an intact blood-brain barrier in brain tissue transplants is dependent on the site of transplantation. <i>Cell transplantation</i> 5(2) 305–314. DOI:<a href=&quot;https://doi.org/10.1177/096368979600500219&quot;>10.1177/096368979600500219</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8689041/&quot;>https://pubmed.ncbi.nlm.nih.gov/8689041</a></p></li><li><p>Li, J, et al., &amp; Hou, D (2018). Montmorillonite/chitosan nanoparticles as a novel controlled-release topical ophthalmic delivery system for the treatment of glaucoma. <i>International journal of nanomedicine</i> 13 3975–3987. DOI:<a href=&quot;https://doi.org/10.2147/IJN.S162306&quot;>10.2147/IJN.S162306</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30022821/&quot;>https://pubmed.ncbi.nlm.nih.gov/30022821</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end S01KX02;
